AIMC Topic: Kidney Neoplasms

Clear Filters Showing 441 to 450 of 530 articles

[Usage of artificial intelligence in the clinical practice of urologists in observations with renal parenchymal neoplasms].

Urologiia (Moscow, Russia : 1999)
OBJECTIVE: to assess the needs and attitudes of urologists regarding the use of technologies related to artificial intelligence, particularly the web platform "Sechenov.AI_nephro", in the surgical treatment of patients with renal parenchymal neoplasm...

Predicting postoperative prognosis in clear cell renal cell carcinoma using a multiphase CT-based deep learning model.

Abdominal radiology (New York)
BACKGROUND: Some clinicopathological risk stratification systems (CRSSs) such as the leibovich score have been used to predict the postoperative prognosis of patients with clear cell renal cell carcinoma (ccRCC), but there are no reliable noninvasive...

Integrating Bioinformatics and Machine Learning to Identify Glucose Metabolism-Related Biomarkers with Diagnostic and Prognostic Value for Patients with Kidney Renal Clear Cell Carcinoma.

Archivos espanoles de urologia
BACKGROUND: Glucose metabolism plays a critical role in the development and progression of kidney renal clear cell carcinoma (KIRC). This study aimed to identify glucose metabolism-related biomarkers (GRBs) and therapeutic targets for KIRC diagnosis ...

Differentiating between renal medullary and clear cell renal carcinoma with a machine learning radiomics approach.

The oncologist
BACKGROUND: The objective of this study was to develop and validate a radiomics-based machine learning (ML) model to differentiate between renal medullary carcinoma (RMC) and clear cell renal carcinoma (ccRCC).

Preoperative kidney tumor risk estimation with AI: From logistic regression to transformer.

PloS one
We consider the problem of renal mass risk classification to support doctors in adjuvant treatment decisions following nephrectomy. Recommendation of adjuvant therapy based on the mass appearance poses two major challenges: first, morphologic pattern...

Autoencoder techniques for survival analysis on renal cell carcinoma.

PloS one
Survival is the gold standard in oncology when determining the real impact of therapies in patients outcome. Thus, identifying molecular predictors of survival (like genetic alterations or transcriptomic patterns of gene expression) is one of the mos...

Predicting tumor mutation burden and VHL mutation from renal cancer pathology slides with self-supervised deep learning.

Cancer medicine
BACKGROUND: Tumor mutation burden (TMB) and VHL mutation play a crucial role in the management of patients with clear cell renal cell carcinoma (ccRCC), such as guiding adjuvant chemotherapy and improving clinical outcomes. However, the time-consumin...